Table 4.
Schedule of screening, enrollment, intervention, assessments, and follow-up visits in the clinical trial.
|
|
Screening | Baseline | Day 8 | Day 30 | Day 60 |
| Determine eligibility based on the inclusion and exclusion criteria | ✓ |
|
|
|
|
| Provision of participant information sheet | ✓ |
|
|
|
|
| Informed consent | ✓ |
|
|
|
|
| Recording of ODIa score | ✓ | ✓ | ✓ | ✓ | ✓ |
| Demographic and medical history | ✓ | ✓ |
|
|
|
| MRIb investigation | ✓ |
|
|
|
|
| Laboratory investigations | ✓ |
|
|
|
✓ |
| General physical examination | ✓ |
|
|
|
|
| Clinical examination | ✓ | ✓ | ✓ | ✓ | ✓ |
| Assessment of subjective parameters |
|
✓ | ✓ | ✓ | ✓ |
| Drug compliance assessment |
|
|
✓ | ✓ |
|
| Rescue medication assessment |
|
|
✓ | ✓ | ✓ |
| Adverse event assessment |
|
|
✓ | ✓ | ✓ |
aODI: Oswestry Disability Index.
bMRI: magnetic resonance imaging.